PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT

Clinical trials for PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT explained in plain language.

Never miss a new study

Get alerted when new PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT trials appear

Sign up with your email to follow new studies for PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Lithium tested as potential treatment for rare genetic brain disorder

Disease control Recruiting now

This study is testing whether a drug called lithium carbonate can help improve daily living skills and behavior in people with a rare genetic condition called TBR1-related neurocognitive disorder. The trial will involve about 12 participants, aged 6 and older, who have a confirme…

Matched conditions: PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT

Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT

Get alerted when new PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT trials appear

Lithium tested as potential treatment for rare genetic brain disorder